Skip to main content

Table 1 Metabolic risk health service evaluation framework

From: Can a pharmacy intervention improve the metabolic risks of mental health patients? Evaluation of a novel collaborative service

Process Indicators [17, 22, 23]

Outcome Indicators [17, 18]

Quality Indicators [20, 21, 24]

• Patient initiation with the metabolic clinic i.e. through the government mental health service

• Enrolment process

• Case load, i.e. how many patients can be managed, workload implications, time per consultation

• Management of patients’ issues at the lowest appropriate level (i.e. lowest primary health care level and minimum level of service)

• Service components provided by nurse practitioner vs pharmacist vs pharmacy assistant

• Process involved in outcomes reporting [17]

• Referrals and associated communication [23]

• Follow-up of the patient [23]

• Consultation fee (eligibility for funded services vs fee-for service)

• Data recorded at different points of consultation [22]

• Baseline data collection [22]

• Mode of documentation [23]

• Monitoring of patient improvement and evaluation of progression [21]

• Qualitative data (free-text notes, reflections) [18]

• Patient compliance with medication, relative to adverse effects experienced, pill counting and dispensing or supply intervals [18]

• Improvement in overall health status of patient (physical and mental health)

• Data collected (e.g. biometric parameters, subjective assessments, patients’ concerns) [17]

• Review of the data/readings obtained [18]

• Patient privacy and confidentiality [21]

• Treatment plan customisation for each patient [20]

• Level of patient assessment. Is it only based on improving physical symptoms (confirmed by lab tests), or does it also include psychological and emotional improvement? [20, 24]

• Patient education regarding their condition, treatment and medication side effects [20]

• Simplicity of information (verbal and written) provided to patients (review sources of information) [20]

• Up-to-date record keeping [20]

• Level of pharmacists’ communication with other health professionals [20, 21]

• Staff understanding that mental health patients may feel stigmatised and hence treat patients in an understanding manner (staff completing training specific to mental health) [20]

• Pharmacist involvement in professional development courses to enhance knowledge in providing the disease state management service [21]

• Promotional activities undertaken in relation to mental health, as a form of encouragement for current patients [20]

• Improvements in the metabolic clinic service